$49.52
Value $3.1B
Guardian Pharmacy ServicesvsProcter & Gamble
GRDN and PG stock compared: price, dividend, valuation and results, from SEC filings.
+0.28%
$169.80
Value $395B
Guardian Pharmacy Services (GRDN) has a market value of $3.1B and Procter & Gamble (PG) $395B. Over the last year, with dividends, GRDN moved +57.0% and PG +18.0%. The P/E is 42.0 for GRDN and 25.1 for PG. Dividend yield: GRDN none, PG 2.55%.
At a glance
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
GRDN$3.1B
PG$395B
PG is 126 times GRDN
Revenue, 12 months
GRDN$1.5B
PG$87.9B
PG is 60 times GRDN
Net income, 12 months
GRDN$75M
PG$16.0B
PG is 214 times GRDN
Operating margin
GRDN6.5%
PG22.6%
16.1 points apart
ROIC
GRDN28.8%
PG17.3%
11.5 points apart
P/E
GRDN42.0
PG25.1
GRDN is 1.7 times PG
Dividend yield
GRDN0.0%
PG2.6%
2.6 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
The price over time
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
GRDN+57.0%
PG+18.0%
| Period | GRDNWith dividends | PGWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +57.0%Price +57.0% | +18.0%Price +14.7% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
Every figure
As on each company's page. A description, not a recommendation: no one figure says which is better.
GRDNGuardian Pharmacy ServicesPGProcter & Gamble
Valuation
GRDNPG| Price | $49.52 | $169.80 |
|---|---|---|
| Market value | $3.1B | $395B |
| Enterprise value (EV) | $3.0B | $418B |
| P/E | 42.0 | 25.1 |
| P/E, 5-year median | – | 24.8 |
| P/B | 11.2 | 7.2 |
| EV/EBIT | 32.1 | 21.1 |
| Free cash flow yield | 2.8% | 3.9% |
Results and growth
GRDNPG| Revenue, 12 months | $1.5B | $87.9B |
|---|---|---|
| Net income, 12 months | $75M | $16.0B |
| Free cash flow, 12 months | $87M | $15.3B |
| Earnings per share, 12 months | $1.18 | $6.64 |
| Revenue growth, year on year | 17.9% | 3.3% |
| Revenue growth a year, past | +17.9%over 1 years | +2.7%over 5 years |
| EPS growth a year, past | – | +3.8%over 5 years |
Margins and returns on capital
GRDNPG| Gross margin | 22.5% | 49.8% |
|---|---|---|
| Operating margin | 6.5% | 22.6% |
| Net margin | 5.1% | 18.2% |
| ROIC | 28.8% | 17.3% |
| ROE | 31.6% | 29.5% |
Balance sheet
GRDNPG| Cash | $120M | $15.4B |
|---|---|---|
| Total debt | $36M | $38.9B |
| Net debt / EBITDA | -1.0 | 1.0 |
| Interest cover | 145.3× | 22.0× |
Dividends and buybacks
GRDNPG| Dividend yield | – | 2.6% |
|---|---|---|
| Dividend per share, 12 months | – | $4.32 |
| Dividend growth a year, past | – | +5.6%over 5 years |
| Buyback yield | – | 1.3% |
| Shareholder yield | – | 3.8% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
Which is bigger, Guardian Pharmacy Services or Procter & Gamble?
By market value, Procter & Gamble ($395B) is about 125.8 times Guardian Pharmacy Services ($3.1B), at today's prices.
How did GRDN and PG stock do over the last 1 years?
Since November 12, 2025, GRDN's price moved +57.0% and PG's +14.7%. With dividends: GRDN +57.0% (+57.0% a year), PG +18.0% (+18.0% a year). Past returns do not predict future ones.
Which pays the higher dividend, GRDN or PG?
The dividend yield at today's price is none for Guardian Pharmacy Services and 2.55% for Procter & Gamble. Over the last twelve months they paid – and $4.32 per share.
What is the P/E of GRDN and PG?
At today's price, the P/E is 42.0 for GRDN and 25.1 for PG. It is the share price over the last twelve months' earnings per share.
Which has the higher profit margins, Guardian Pharmacy Services or Procter & Gamble?
Over the last twelve months, the net margin was 5.1% for Guardian Pharmacy Services and 18.2% for Procter & Gamble, and the operating margin 6.5% and 22.6%. Revenue was $1.5B and $87.9B.
Which is the better investment, Guardian Pharmacy Services or Procter & Gamble?
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
Other comparisons
With each of the two, and with the largest in its sector.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.
Descriptive data from SEC filings and market prices.